HUTCHMED (China) Limited
NASDAQ:HCM · NASDAQ Global Select
+$0.16 today
Vol 0.05M · Avg 0.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-32.41%
Period High
$19.21
Period Low
$10.12
Latest
$10.28
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.55B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$4.09B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.92B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.77B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.55B
Bausch Health Companies Inc.
NYSE:BHC
$1.74B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.69B
Perrigo Company plc
NYSE:PRGO
$1.37B
What is the latest HCM filing?
The latest filing shown is 6-K dated Jun 12, 2026.
How many recent filings does HCM have?
Intrinsic Alpha currently shows 20 recent filings for HCM.
Explore More
Continue the stock analysis
Jump to another research area for this company.